Akari Therapeutics Plc ADR’s recently made public that its CEO Gaslightwala Abizer acquired Company’s shares for reported $9400.0 on Aug 21 ’25. In the deal valued at $0.94 per share,10,000 shares were bought. As a result of this transaction, Gaslightwala Abizer now holds 287,574 shares worth roughly $0.2 million.
Then, Gaslightwala Abizer bought 8,000 shares, generating $7,440 in total proceeds. Upon buying the shares at $0.93, the CEO now owns 295,574 shares.
Before that, Gaslightwala Abizer bought 3,000 shares. Akari Therapeutics Plc ADR shares valued at $2,700 were divested by the CEO at a price of $0.90 per share. As a result of the transaction, Gaslightwala Abizer now holds 298,574 shares, worth roughly $0.21 million.
Maxim Group initiated its Akari Therapeutics Plc ADR [AKTX] rating to a Buy in a research note published on July 18, 2025; the price target was $5. A number of analysts have revised their coverage, including B. Riley FBR’s analysts, who increased its forecast for the stock in early January from “a Neutral” to “a Buy”. B. Riley FBR Inc. began covering AKTX with “Neutral” recommendation on February 08, 2018. William Blair revised its rating on September 22, 2017. It rated AKTX as “an Outperform” which previously was an “a Mkt perform”.
Price Performance Review of AKTX
On Tuesday, Akari Therapeutics Plc ADR [NASDAQ:AKTX] saw its stock fall -7.91% to $0.7. Over the last five days, the stock has lost -20.92%. Akari Therapeutics Plc ADR shares have fallen nearly -81.58% since the year began. Nevertheless, the stocks have fallen -42.63% over the past one year. While a 52-week high of $3.87 was reached on 03/20/25, a 52-week low of $0.75 was recorded on 09/02/25.
Levels Of Support And Resistance For AKTX Stock
The 24-hour chart illustrates a support level at 0.5909, which if violated will result in even more drops to 0.4818. On the upside, there is a resistance level at 0.7895. A further resistance level may holdings at 0.8790.
How much short interest is there in Akari Therapeutics Plc ADR?
A steep rise in short interest was recorded in Akari Therapeutics Plc ADR stocks on 2025-08-15, growing by 40214.0 shares to a total of 76916.0 shares. Yahoo Finance data shows the prior-month short interest on 2025-07-15 was 36702.0 shares. There was a rise of 52.28%, which implies that there is a positive sentiment for the stock.
